Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center

Keyphrases

• 5-year Survival 18%
• Adult Lung 100%
• Bronchiolitis Obliterans Syndrome 45%
• Cystic Fibrosis 9%
• Emphysema 9%
• End-stage Lung Disease 9%
• Hospital Mortality 9%
• Improved Outcomes 9%
• Long-term Survival 9%
• Low Dose Rate 9%
• Lung Transplantation 100%
• Primary Graft Dysfunction 100%
• Pulmonary Fibrosis 9%
• Pulmonary Vascular Disease 9%
• Recipient Age 9%
• Single Center 100%
• Single Institution 9%
• University of Washington 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Bronchiolitis Obliterans 45%
• Cystic Fibrosis 9%
• Emphysema 9%
• Hospital Mortality 9%
• Long Term Survival 9%
• Lung Disease 9%
• Lung Fibrosis 9%
• Primary Graft Dysfunction 100%
• Pulmonary Vascular Disease 9%
• Syndrome 45%